We are live on
!
Find out more
Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
17 hedge funds and large institutions have $11.3M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
23% less capital invested
Capital invested by funds: $14.6M → $11.3M (-$3.31M)
Holders
17
Holding in Top 10
–
Calls
$17.3M
Puts
$9.41M
Top Buyers
| 1 | +$1.9M | |
| 2 | +$1.24M | |
| 3 | +$1.23M | |
| 4 |
Goldman Sachs
New York
|
+$1.12M |
| 5 |
CF
Cantor Fitzgerald
New York
|
+$965K |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$1.08M | |
| 3 | -$946K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$833K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$762K |
